直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

製藥

About

製藥 業務的一部分 生命科學.

突破性發現和創新 需要強有力的保護

人們仰賴製藥產業提供改善生活品質的救命藥物和治療方法。即使在研發上投入數十億美元,也只有少許新藥能通過臨床試驗和符合進入市場所需的嚴格監管許可。對於這樣的企業,至關重要的是,公司必須保護奠基新藥和療法的智慧財產。Finnegan飛翰與創新的製藥公司合作已有悠久的歷史,旨於保護和最大化其寶貴的智財權與資產,為智財申請和組合擬訂策略。

了解法律,科學,和技術

我們客戶的業務和智財資產是全球性的,在各轄區保護這些資產變得越來越挑戰。結合我們在全球設立的據點和與跨國公司的合作經驗,Finnegan飛翰擁有的資源和經驗,得以為製藥公司制訂及執行全球戰略。因應新發現及其商業應用的快速進展,需要對智財權的法律議題和產業的理解能夠充分掌握,以洞悉這些進步的科學和戰略意涵。

憑藉為製藥客戶解決幾乎各類型之智財議題的經驗,我們透過以下方式提供協助:

  • 代表客戶處理複雜的藥品專利侵權和營業秘密案件,包括Hatch-Waxman訴訟
  • 透通經驗豐富的審判和上訴團隊的成軍,在地院和上訴法院應戰高價值商品的訴訟案件
  • 制訂和執行申請策略,以保護客戶的產品,以及分析競爭對手的產品,從而確保客戶理解其智財資產的價值
  • 授權的準備與談判,評估競爭對手專利的授權價值,並指引客戶做出決定
  • 對購併與合夥的目標公司做盡職調查
  • 就與營運有關的事宜提供諮詢,包括反托拉斯和競爭議題
  • 確認複雜之專利衝突訴訟的優先權爭議
  • 就可能的訴訟提供策略諮詢,並在法院主張和捍衛專利權
  • 提供商標申請和諮詢服務

我們與客戶一起在眾多領域中致力科學的創新與推進,包括:

  • 抗體療法-大分子和小分子
  • 非典型抗精神病藥物
  • 緩釋製劑
  • 疫苗

保護創新之全面的法律,技術,和策略經驗

我們的生命科學業務由250多位律師和專業人士組成,致力於滿足客戶對於智財權服務的需求。多數擁有與生物學,化學,生物化學,醫學,藥理學,或生醫工程等相關學科的高階學位。大多具有紮實的研究和/或產業經驗,許多人在產業或大學任職,或在美國專利商標局擔任審查委員後加入Finnegan飛翰。

Everyone in this industry

Experience

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products.

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias.

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers.

Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company*

Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company.

Represented a global pharmaceutical company against a generic company on a patent covering an injectable painkilling medicine for short-term pain relief*

Represented a global pharmaceutical company against a generic company on a patent covering an injectable painkilling medicine for short-term pain relief.

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer.

More

Insights

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

At the PTAB Blog

Squires Issues Precedential Decision Clarifying Obviousness-Type Double Patenting Rejections

August 17, 2026

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

Genus Claiming (Including Means Plus Function “MPF” Claiming) in Biotech and Pharma: Doctrinal Trajectory and Drafting Strategies

June 2026

More

Upcoming Events

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

News

Award/Ranking

Fourteen Finnegan Attorneys Named to the 2026 IAM Strategy 300 List

August 13, 2026

Award/Ranking

Partner Jeffrey M. Jacobstein Named Finalist for New England Legal Awards

August 10, 2026

Award/Ranking

Finnegan Shortlisted in 13 Categories at the 2026 LMG Life Sciences America Awards

July 15, 2026

Commentary

Finnegan Taps Partner from Kirkland to Boost IP Team

June 12, 2026

Media Mention

Finnegan Hires Kirkland & Ellis Litigator for London Office

June 8, 2026

Commentary

Finnegan Hires Kirkland Partner as It Eyes UK Growth

June 8, 2026

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP